Literature DB >> 9002395

Pemoline augmentation for resistant depression.

F Benazzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9002395      PMCID： PMC1188825     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

Review 1.  Depression and Parkinson's disease: a review.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

Review 2.  Psychostimulants in psychiatry.

Authors:  L Warneke
Journal:  Can J Psychiatry       Date:  1990-02       Impact factor: 4.356

3.  Methylphenidate in depressed medically ill patients.

Authors:  P B Rosenberg; I Ahmed; S Hurwitz
Journal:  J Clin Psychiatry       Date:  1991-06       Impact factor: 4.384

4.  CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.

Authors:  J Fawcett; H M Kravitz; J M Zajecka; M R Schaff
Journal:  J Clin Psychopharmacol       Date:  1991-04       Impact factor: 3.153

5.  Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.

Authors:  A L Stoll; S S Pillay; L Diamond; S B Workum; J O Cole
Journal:  J Clin Psychiatry       Date:  1996-02       Impact factor: 4.384

6.  Combination of fluoxetine with pemoline in the treatment of major depressive disorder.

Authors:  A Metz; R I Shader
Journal:  Int Clin Psychopharmacol       Date:  1991       Impact factor: 1.659
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.